MK-677
Typical Dosage
10-25 mg
Administration
Oral
Half-Life
Approximately 24 hours
Mechanism of Action
GH/IGF-1 axis studies|Sleep and recovery research|Appetite signaling|Body-composition research
Research Protocol Summary
Evidence Level
Early Human / Investigational
Typical Protocol Duration
8-16 weeks
Species Studied
Human • Rat
Administration Schedule
Daily
Timing Notes
PM
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…